The company demonstrated a significant reduction in time on the waitlist for patients treated with imlifidase compared to matched controls at the 2019 American Transplant Congress, June 1 – 5, in Boston, Massachusetts, USA. In a plenary presentation on June 5, 2019, Edmund Huang, Associate PAlready a subscriber Login You have…